ArticlePloS one2025
Association of 25(OH)D serum level with biological aging: A Cross-Sectional Study of 2007-2016 NHANES surveys.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Biological Aging Mediates the Associations Between Multiple Serum Micronutrients and All-Cause Mortality Among U.S. Adults.Biological trace element research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin D plays a crucial role in various aspects of human body, including aging, but chronological age may not accurately reflect the true biological aging status. Recently, PhenoAge has been developed to estimate an individual's biological age based on different biological and clinical measures. Therefore, we investigated the relationship between 25(OH)D serum levels and biological aging calculated by PhenoAge Acceleration (PhenoAgeAccel) using data from the 2007-2016 National Health and Nutrition Examination Survey (NHANES). 25(OH)D serum levels were negatively associated with PhenoAgeAccel (β = -0.04 standard deviation [SD]; 95% confidence interval [CI]: -0.08 to 0.00). This negative association was dose-dependent in females (β = -0.07 SD; 95% CI: -0.12 to 0.01), but not in males. Generalized additive models further revealed gender-specific non-linear patterns: a U-shape pattern in males but an L-shaped pattern in females. Using segmented regression to confirm inflection points, we observed that 25(OH)D serum levels were linked to reduced PhenoAgeAccel at levels below 38.2 nmol/L (15.3 ng/mL) in males (β = -0.013 SD; 95% CI: -0.025 to -0.002) and 62.5 nmol/L (25.0 ng/mL) in females (β = -0.007 SD; 95% CI: -0.01 to -0.004,). However, 25(OH)D serum levels above 125 nmol/L showed no association with PhenoAgeAccel in females (β = -0.001 SD; 95% CI: -0.005-0.002), while in males, elevated levels (>91.6 nmol/L) were associated with increased PhenoAgeAccel (β = 0.005 SD; 95% CI: 0.002-0.008). Our findings indicate that vitamin D insufficiency has an inverse link with accelerated biological aging, and high levels of vitamin D in males accelerated biological aging as well, offering valuable insights into the relationship between vitamin D and biological aging.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.